Since founding Waud Capital Partners in Lake Forest, Illinois in 1993, Reeve Waud has completed over 500 company acquisitions across healthcare and technology sectors, building one of the middle market’s most focused private equity platforms. The firm’s latest move—a $100+ million commitment to build a medical device platform with executive Bill Mixon—illustrates how Waud’s investment approach has adapted while maintaining core principles developed over three decades.
The partnership demonstrates institutional capabilities that extend far beyond capital provision. Waud Capital Partners has evolved from a single-person operation into a comprehensive platform managing approximately $4.6 billion in assets under management as of 2022, with specialized resources for healthcare sector investments. Reeve Waud’s systematic approach to building healthcare platforms reflects accumulated knowledge from successful investments like Acadia Healthcare and more recent exits including the $2.2 billion GI Alliance recapitalization.
The Ecosystem Advantage
Waud Capital Partners has developed what the firm describes as an “ecosystem” approach, combining capital with operational expertise, business development resources, and human capital teams. This infrastructure supports portfolio companies beyond traditional private equity financial investment, providing specialized resources for healthcare platform development and operational improvement initiatives.
The ecosystem includes dedicated professionals for business development, human capital, operations, and sector research. Kyle Lattner referenced “the full ecosystem of resources to execute transformative growth strategies in large, growing markets” when describing the firm’s executive partnership approach. These resources enable portfolio companies to accelerate growth initiatives and operational improvements that might otherwise require years to develop internally.
Healthcare investments particularly benefit from specialized sector knowledge and operational expertise. Building successful healthcare platforms requires understanding complex regulatory environments, reimbursement systems, clinical operations, and patient service requirements. Waud Capital’s accumulated experience across multiple healthcare investments creates competitive advantages for new platform development initiatives.
The ecosystem approach enables executive partnerships like the Mixon collaboration, where substantial capital commitments support platform development before identifying specific acquisition targets. This requires confidence in both market opportunity and institutional capability to execute complex healthcare consolidation strategies.
Healthcare Sector Focus Evolution
Reeve Waud’s healthcare investment evolution reflects both market opportunities and institutional learning over three decades. Early investments built foundational knowledge about healthcare services markets, leading to more targeted focus areas and sophisticated platform development strategies.
The founding of Acadia Healthcare in 2005 represented a watershed moment for Waud’s healthcare investment approach. Building the behavioral health platform from startup to public company demonstrated how systematic consolidation could create substantial value in fragmented healthcare sectors. Acadia’s growth to over 260 facilities across 40 states and Puerto Rico before its 2011 initial public offering validated the consolidation thesis that informs current investment strategies.
Recent healthcare investments demonstrate evolved sector focus on infrastructure and support services. The portfolio includes Mopec Group (pathology equipment and consumables), PromptCare (home infusion and durable medical equipment), Provider Network Holdings (specialty medication supply management), DS Medical (home medical supplies), AltoCare (in-home senior care), and Concierge Home Care (skilled healthcare).
These investments reflect shifts toward healthcare services that benefit from scale advantages, have recurring revenue characteristics, and face less direct regulatory pressure than traditional healthcare delivery. The focus on supply chain services, home care, and specialty distribution aligns with broader healthcare industry trends favoring outsourcing of non-core functions.
Capital Commitment and Scale
Waud Capital Partners has grown from single-person operation to managing $4.6 billion in assets under management as of 2022, reflecting successful fundraising and investor returns over multiple fund cycles. The growth enables larger platform investments like the over $100 million commitment to the Mixon partnership.
Fund size progression demonstrates institutional confidence in Waud’s investment approach. Earlier funds built track record and investor relationships, while larger recent funds enable more ambitious platform development strategies and multiple simultaneous investments in target sectors.
The scale provides competitive advantages in executive partnerships and acquisition opportunities. Healthcare executives like Bill Mixon evaluate private equity partners based on capital availability, sector expertise, and operational resources. Waud Capital’s combination of financial resources and healthcare sector knowledge creates attractive partnership opportunities for proven healthcare operators.
Learn More: Private Equity and Hedge Funds: Navigating the Alternatives Shift — Private Credit, Secondaries & ESG
Operational Excellence Focus
Reeve Waud’s approach emphasizes operational improvement as a primary value creation driver, particularly in healthcare investments where service quality and regulatory compliance create competitive advantages. The firm’s resources include operational expertise for healthcare platform development, clinical operations, and regulatory compliance.
Bill Mixon’s previous success at Advanced Diabetes Supply exemplifies the type of operational improvement that creates value in healthcare consolidation. He drove “transformational growth by professionalizing the organization through salesforce productivity enhancements, executing a shift in go-to-market initiatives, and delivering margin improvements through revenue cycle initiatives and other operational efficiencies.”
The emphasis on operational excellence reflects Waud Capital’s understanding that healthcare investments require more than financial engineering to generate sustainable returns. Clinical quality, patient satisfaction, regulatory compliance, and operational efficiency create competitive moats that support long-term value creation.
Current market opportunities in medical device and supply chain services align with Waud Capital Partners’ operational improvement capabilities. These sectors benefit from professional management, technology investments, and operational scale that create competitive advantages for well-funded platforms. Reeve Waud’s three-decade evolution from individual investor to healthcare platform builder positions the firm to capitalize on consolidation opportunities that require both capital and operational expertise.
Learn more: Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
